Semnur Pharmaceuticals, Inc. Deferred Tax Assets, Operating Loss Carryforwards
Semnur Pharmaceuticals, Inc. (SMNR) had Deferred Tax Assets, Operating Loss Carryforwards of $38.35 million as of 2025-12-31, per its S-1 filed 2026-05-12.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Operating Loss Carryforwards, Components
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-05-12
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $38.35M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $14.52M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards |
|---|---|
| 2025-12-31 | $38.35M S-1 · filed 2026-05-12 |
| 2024-12-31 | $14.52M S-1 · filed 2026-05-12 |